HSD13 Factors Associated with Prescribing of Teriflunomide and Dimethyl Fumarate Versus Fingolimod in Multiple Sclerosis
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.1015
https://www.valueinhealthjournal.com/article/S1098-3015(22)01216-5/fulltext
Title :
HSD13 Factors Associated with Prescribing of Teriflunomide and Dimethyl Fumarate Versus Fingolimod in Multiple Sclerosis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)01216-5&doi=10.1016/j.jval.2022.04.1015
First page :
Section Title :
Open access? :
No
Section Order :
10917